Interestingly, in a melanoma mouse model, HDAC6 inhibitor Nexturastat A given in conjunction with anti-PD-1 antibodies significantly impaired tumor growth by causing a decrease in the anti-inflammatory phenotype of macrophages and increased infiltration of CD8+ T cells and NK cells into the TME [278]. This evidence concerns the gene HDAC6 and melanoma.